[1]
M. Mencinger, D. Mangaroski, and U. Bokal, “Disease control with prior platinum-based chemotherapy is prognostic for survival in patients with metastatic urothelial cancer treated with atezolizumab in real-world practice”, RO, vol. 55, no. 4, pp. 491–498, Dec. 2021.